Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Febuxostat versus allopurinol in hyperuricemia and gout
2012-001858-25Phase 4Completed
- Sponsor
- Menarini Group
- Start
- Nov 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in hyperuricemia and gout comparing Febuxostat arm with Allopurinol arm (2 arms). Primary endpoint: Serum urate response at week 4. Started Nov 2012; status: completed.
02
Drugs
febuxostatallopurinol
03
Conditions
hyperuricemiagout
Beyond the preview
Go deeper on 2012-001858-25.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-001858-25.